abstract |
The invention provides (2S, 3R, 4R, 5S, 6R) -2- (3-((5- (4-fluorophenyl) thiophen-2-yl) methyl) -4-methylphenyl) -6- (hydr L-proline and citric acid cocrystals of oxymethyl) tetrahydro-2H-pyran-3,4,5-triol, pharmaceutical compositions containing these cocrystals, and glucose-related disorders, such as type 2 diabetes mellitus And their use in the treatment of syndrome X. |